mlck inhibitor peptide 18 Search Results


mlck inhibitor peptide 18  (MedChemExpress)
94
MedChemExpress mlck inhibitor peptide 18
FIGURE 5 Cell growth under perfusion with/without inhibitors of actomyosin contractility. (a) Rhosin chloride (Rhosin), Y27632 dihydrochloride (Y27632), MLCK inhibitory <t>peptide</t> <t>18</t> (MLCK ip 18), and Blebbistatin (203390) were added to the culture medium during the dynamic cell culture, leading forcible cell relaxation. (b, c) The quantification of double strand DNA (dsDNA) demonstrated the cells in the dynamic culture were less proliferative compared to the static counterpart. The inhibition of actomyosin contractility mitigated cell proliferation in the dynamic but not static conditions. Dunnett's multiple comparison was performed by comparing to DMSO control within static and dynamic conditions. (d, e) EdU (5-ethynyl-20-deoxyuridine) incorporation during 24 hours of cell culture, detected by confocal microscope, decreased in the dynamic condition, particularly in the presence of the inhibitors. Statistical comparison between the static and dynamic conditions without the inhibitors was performed by Student's t-test and within the groups by ANOVA followed by Dunnett's multiple comparison. *p < 0.05; **p < 0.01. Scale bar = 100 μm.
Mlck Inhibitor Peptide 18, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mlck+inhibitor+peptide+18/MLCK+inhibitor+peptide+18/pm37206242-53-21-29
Average 94 stars, based on 1 article reviews
mlck inhibitor peptide 18 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
mlck inhibitor peptide 18  (Bio-Techne corporation)
90
Bio-Techne corporation mlck inhibitor peptide 18
FIGURE 5 Cell growth under perfusion with/without inhibitors of actomyosin contractility. (a) Rhosin chloride (Rhosin), Y27632 dihydrochloride (Y27632), MLCK inhibitory <t>peptide</t> <t>18</t> (MLCK ip 18), and Blebbistatin (203390) were added to the culture medium during the dynamic cell culture, leading forcible cell relaxation. (b, c) The quantification of double strand DNA (dsDNA) demonstrated the cells in the dynamic culture were less proliferative compared to the static counterpart. The inhibition of actomyosin contractility mitigated cell proliferation in the dynamic but not static conditions. Dunnett's multiple comparison was performed by comparing to DMSO control within static and dynamic conditions. (d, e) EdU (5-ethynyl-20-deoxyuridine) incorporation during 24 hours of cell culture, detected by confocal microscope, decreased in the dynamic condition, particularly in the presence of the inhibitors. Statistical comparison between the static and dynamic conditions without the inhibitors was performed by Student's t-test and within the groups by ANOVA followed by Dunnett's multiple comparison. *p < 0.05; **p < 0.01. Scale bar = 100 μm.
Mlck Inhibitor Peptide 18, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mlck+inhibitor+peptide+18/MLCK+Inhibitor+Peptide+18/pmc10189446-54-21-9
Average 90 stars, based on 1 article reviews
mlck inhibitor peptide 18 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
mlck inhibitor peptide 18  (Tocris)
93
Tocris mlck inhibitor peptide 18
FIGURE 5 Cell growth under perfusion with/without inhibitors of actomyosin contractility. (a) Rhosin chloride (Rhosin), Y27632 dihydrochloride (Y27632), MLCK inhibitory <t>peptide</t> <t>18</t> (MLCK ip 18), and Blebbistatin (203390) were added to the culture medium during the dynamic cell culture, leading forcible cell relaxation. (b, c) The quantification of double strand DNA (dsDNA) demonstrated the cells in the dynamic culture were less proliferative compared to the static counterpart. The inhibition of actomyosin contractility mitigated cell proliferation in the dynamic but not static conditions. Dunnett's multiple comparison was performed by comparing to DMSO control within static and dynamic conditions. (d, e) EdU (5-ethynyl-20-deoxyuridine) incorporation during 24 hours of cell culture, detected by confocal microscope, decreased in the dynamic condition, particularly in the presence of the inhibitors. Statistical comparison between the static and dynamic conditions without the inhibitors was performed by Student's t-test and within the groups by ANOVA followed by Dunnett's multiple comparison. *p < 0.05; **p < 0.01. Scale bar = 100 μm.
Mlck Inhibitor Peptide 18, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mlck+inhibitor+peptide+18/MLCK+Inhibitor+Peptide+18/pmc12561949-38-1-12
Average 93 stars, based on 1 article reviews
mlck inhibitor peptide 18 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
mlck inhibitor peptide 18  (BOC Sciences)
N/A
A myosin light chain kinase (MLCK) inhibitor (IC50= 50 nM), and inhibits CaM kinase IIonly at 4000-fold higher concentrations.
   Buy from Supplier
mlck inhibitor peptide 18 tfa  (Aladdin Scientific Corporation)
N/A
MLCK inhibitor peptide 18 TFA is a myosin light chain kinase (MLCK) inhibitor with an IC50 of 50 nM, and inhibits CaM kinase II only at 4000-fold higher concentrations.
   Buy from Supplier
mlck inhibitor peptide 18 acetate  (TargetMol)
N/A
   Buy from Supplier
mlck inhibitor peptide 18  (Cayman Chemical)
N/A
MLCK Inhibitor Peptide 18
   Buy from Supplier
mlck inhibitor peptide 18  (Biosynth Carbosynth)
N/A
   Buy from Supplier
mlck inhibitor peptide 18  (MuseChem Chemicals)
N/A
Selective competitive inhibitor of myosin light chain kinase (IC50 = 50 nM). Displays 4000-fold selectivity over CaM kinase II and does not inhibit PKA. Cell permeable.
   Buy from Supplier
mlck inhibitor peptide 18  (TargetMol)
N/A
   Buy from Supplier
mlck inhibitor peptide 18  (1PlusChem LLC)
N/A
MLCK INHIBITOR PEPTIDE 18
   Buy from Supplier

Image Search Results


FIGURE 5 Cell growth under perfusion with/without inhibitors of actomyosin contractility. (a) Rhosin chloride (Rhosin), Y27632 dihydrochloride (Y27632), MLCK inhibitory peptide 18 (MLCK ip 18), and Blebbistatin (203390) were added to the culture medium during the dynamic cell culture, leading forcible cell relaxation. (b, c) The quantification of double strand DNA (dsDNA) demonstrated the cells in the dynamic culture were less proliferative compared to the static counterpart. The inhibition of actomyosin contractility mitigated cell proliferation in the dynamic but not static conditions. Dunnett's multiple comparison was performed by comparing to DMSO control within static and dynamic conditions. (d, e) EdU (5-ethynyl-20-deoxyuridine) incorporation during 24 hours of cell culture, detected by confocal microscope, decreased in the dynamic condition, particularly in the presence of the inhibitors. Statistical comparison between the static and dynamic conditions without the inhibitors was performed by Student's t-test and within the groups by ANOVA followed by Dunnett's multiple comparison. *p < 0.05; **p < 0.01. Scale bar = 100 μm.

Journal: Bioengineering & translational medicine

Article Title: Unique osteogenic profile of bone marrow stem cells stimulated in perfusion bioreactor is Rho-ROCK-mediated contractility dependent.

doi: 10.1002/btm2.10509

Figure Lengend Snippet: FIGURE 5 Cell growth under perfusion with/without inhibitors of actomyosin contractility. (a) Rhosin chloride (Rhosin), Y27632 dihydrochloride (Y27632), MLCK inhibitory peptide 18 (MLCK ip 18), and Blebbistatin (203390) were added to the culture medium during the dynamic cell culture, leading forcible cell relaxation. (b, c) The quantification of double strand DNA (dsDNA) demonstrated the cells in the dynamic culture were less proliferative compared to the static counterpart. The inhibition of actomyosin contractility mitigated cell proliferation in the dynamic but not static conditions. Dunnett's multiple comparison was performed by comparing to DMSO control within static and dynamic conditions. (d, e) EdU (5-ethynyl-20-deoxyuridine) incorporation during 24 hours of cell culture, detected by confocal microscope, decreased in the dynamic condition, particularly in the presence of the inhibitors. Statistical comparison between the static and dynamic conditions without the inhibitors was performed by Student's t-test and within the groups by ANOVA followed by Dunnett's multiple comparison. *p < 0.05; **p < 0.01. Scale bar = 100 μm.

Article Snippet: For the inhibition, 20 μM Rhosin chloride (Rhosin: 5003; Biotechne, UK), 10 μM Y27632 dihydrochloride (Y27632: 1254; Biotechne, UK), 1 μM MLCK inhibitor peptide 18 (MLCK ip 18: HY-P1029; MedChemExpress, USA), or 10 μM Blebbistatin (203390; SigmaAldrich, USA) was added to the culture medium during the dynamic cell culture to inhibit Rho GTPase, Rho-associated coiled-coil containing protein kinase (ROCK), myosin light chain kinase (MLCK), and myosin II, respectively (Figure S1A).

Techniques: Cell Culture, Inhibition, Comparison, Control, Microscopy